Cargando…

Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients

(1) Background: Social distancing rules have been widely introduced in the fight against the coronavirus disease 2019 (COVID-19) pandemic. So far, the effectiveness of these methods has not been assessed in the group of inflammatory bowel disease (IBD) patients. (2) Methods: The study included 473 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Łodyga, Michał, Maciejewska, Katarzyna, Eder, Piotr, Waszak, Katarzyna, Stawczyk-Eder, Kamila, Dobrowolska, Agnieszka, Kaczka, Aleksandra, Gąsiorowska, Anita, Stępień-Wrochna, Beata, Cicha, Małgorzata, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396918/ https://www.ncbi.nlm.nih.gov/pubmed/34441985 http://dx.doi.org/10.3390/jcm10163689

Ejemplares similares

Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2023)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?
por: Krela-Kazmierczak, Iwona, et al.
Publicado: (2018)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland
por: Łodyga, Michał, et al.
Publicado: (2022)

Dietary Support in Elderly Patients with Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2021)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2014)

The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity
por: Eder, Piotr, et al.
Publicado: (2015)

Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Łodyga, Michał, et al.
Publicado: (2021)

Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)
por: Cichoż-Lach, Halina, et al.
Publicado: (2021)

Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies
por: Eder, Piotr, et al.
Publicado: (2015)

Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study
por: Stawczyk-Eder, Kamila, et al.
Publicado: (2015)

Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn’s disease naive to anti-TNF agents
por: Eder, Piotr, et al.
Publicado: (2015)

Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2023)

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Eder, Piotr, et al.
Publicado: (2023)

Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn’s disease
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2015)

Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study
por: Eder, Piotr, et al.
Publicado: (2023)

Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions
por: Eder, Piotr, et al.
Publicado: (2021)

The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

Disturbances in apoptosis of lamina propria lymphocytes in Crohn's disease
por: Eder, Piotr, et al.
Publicado: (2015)

ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s Disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2019)

A Vicious Cycle of Osteosarcopenia in Inflammatory Bowel Diseases—Aetiology, Clinical Implications and Therapeutic Perspectives
por: Skrzypczak, Dorota, et al.
Publicado: (2021)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
por: Winter, Katarzyna, et al.
Publicado: (2019)

Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease
por: Rychter, Anna Maria, et al.
Publicado: (2021)

Socio-demographic characteristics of patients with diagnosed functional dyspepsia
por: Piotrowicz, Grażyna, et al.
Publicado: (2013)

Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?
por: Walczak, Michal, et al.
Publicado: (2020)

Iron Deficiency Anemia in Inflammatory Bowel Diseases—A Narrative Review
por: Mahadea, Dagmara, et al.
Publicado: (2021)

Use of functional magnetic resonance imaging in patients with irritable bowel syndrome and functional dyspepsia
por: Skrobisz, Katarzyna, et al.
Publicado: (2019)

What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2021)

Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population
por: Ostrowski, Jerzy, et al.
Publicado: (2016)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection
por: Konrad, Paulina, et al.
Publicado: (2018)

Obesity and the Brain
por: Karczewski, Jacek, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0jmvst3hg63b3euou7hn20b0g7